Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-25-000020
Filing Date
2025-07-31
Accepted
2025-07-31 08:06:19
Documents
5
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 6-K a6kcoverpagepressreleaseq2.htm 6-K 13025
2 EX-99.1 pressreleaseq22025english.htm EX-99.1 1066383
3 GRAPHIC fsridynmyoja6mzu5ztu0njm3z.gif GRAPHIC 2870
4 GRAPHIC image.jpg GRAPHIC 160159
5 GRAPHIC image1.jpg GRAPHIC 20928
  Complete submission text file 0001121404-25-000020.txt   1334241
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251169520
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)